Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-06-09

Clinical Trial Update: Patient Registry Study of Berinert® in Normal Clinical Practice

View source ↗

Summary

A completed patient registry study assessing the use of Berinert (C1 esterase inhibitor) in normal clinical practice for hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Berinert (C1 esterase inhibitor)

Snippet

Sponsor: CSL Behring | Conditions: Includes: Hereditary Angioedema | Status: COMPLETED